Efficacy and Safety of Bacille Calmette-Guérin Immunotherapy in Superficial Bladder Cancer
Top Cited Papers
Open Access
- 1 September 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (Supplement) , S86-S90
- https://doi.org/10.1086/314064
Abstract
In the United States, bladder cancer is the fourth most common human malignancy. In the past decade, the incidence of bladder cancer has increased byKeywords
This publication has 21 references indexed in Scilit:
- A Randomized Multicenter Trial of Adjuvant Therapy in Superficial Bladder Cancer: Transurethral Resection Only Versus Transurethral Resection Plus Mitomycin C Versus Transurethral Resection Plus Bacillus Calmette-GuerinJournal of Urology, 1996
- Original Articles: Bladder Cancer: A Randomized Study of Intravesical Mitomycin C, Bacillus Calmette-Guerin Tice and Bacillus Calmette-Guerin RIVM Treatment in pTa-pT1 Papillary Carcinoma and Carcinoma in Situ of the BladderJournal of Urology, 1995
- Management of Stage T1 Superficial Bladder Cancer with Intravesical Bacillus Calmette-Guerin TherapyJournal of Urology, 1992
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- A Low Dose Bacillus Calmette-Guerin Regimen in Superficial Bladder Cancer Therapy: Is it Effective?Journal of Urology, 1991
- Comparison of BCG with other intravesical agentsUrology, 1991
- Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.Journal of Clinical Oncology, 1988
- Long-term Fate of 90 Patients with Superficial Bladder Cancer Randomly Assigned to Receive or not to Receive ThiotepaJournal of Urology, 1983
- Tigason® (Etretinate) in Prevention of Recurrence of Superficial Bladder TumorsEuropean Urology, 1983
- Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder TumorsJournal of Urology, 1976